LAUSR

Splicing Factor-Mutant Leukemias Are Sensitive to PRMT Inhibitors.

Sign Up to like & get
recommendations!
0 Published in 2019 at "Cancer discovery"

DOI: 10.1158/2159-8290.cd-rw2019-129

Abstract: Splicing factor mutations increased protein arginine methyltransferase (PRMT) inhibitor sensitivity. read more here.

Keywords: prmt; splicing factor; mutant leukemias; factor mutant ... See more keywords